Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tff Pharmaceuticals Inc (TFFP)

Tff Pharmaceuticals Inc (TFFP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 289
  • Shares Outstanding, K 4,443
  • Annual Sales, $ 730 K
  • Annual Income, $ -21,240 K
  • EBIT $ -19 M
  • EBITDA $ -18 M
  • 60-Month Beta 1.07
  • Price/Sales 0.98
  • Price/Cash Flow N/A
  • Price/Book 0.07
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.44
  • Most Recent Earnings $-0.81 on 11/20/24
  • Next Earnings Date 11/26/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0611 +6.38%
on 12/12/24
1.7997 -96.39%
on 11/13/24
-1.7450 (-96.41%)
since 11/12/24
3-Month
0.0611 +6.38%
on 12/12/24
3.2300 -97.99%
on 10/31/24
-2.1450 (-97.06%)
since 09/12/24
52-Week
0.0611 +6.38%
on 12/12/24
11.0000 -99.41%
on 03/20/24
-8.2100 (-99.21%)
since 12/12/23

Most Recent Stories

More News
TFF Pharmaceuticals, Inc. Announces Termination of Employees and Wind Down of Operations

TFF Pharmaceuticals will terminate employees and cease operations, appointing Craig R. Jalbert as the new CEO.Quiver AI SummaryTFF Pharmaceuticals, Inc. announced the termination of its employees and plans...

TFFP : 0.0650 (-60.05%)
TFF Pharmaceuticals Announces It Will Wind Down Operations

TFFP : 0.0650 (-60.05%)
The Future of Medicine: Drug Delivery Innovations Leading a $700 Billion Market

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – In the field of medicine, many...

LEXX : 2.21 (-1.34%)
BIOV.CN : 0.0600 (unch)
BVAXF : 0.0450 (+0.22%)
TFFP : 0.0650 (-60.05%)
DNTH : 25.58 (-0.12%)
AQST : 3.13 (-2.80%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TFF Pharmaceuticals, Inc. - TFFP

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TFF Pharmaceuticals, Inc. ("TFF" or the "Company") (NASDAQ: TFFP). Such...

TFFP : 0.0650 (-60.05%)
TFF Pharmaceuticals, Inc. (TFFP) Q2 2022 Earnings Call Transcript

TFFP earnings call for the period ending June 30, 2022.

TFFP : 0.0650 (-60.05%)
TFF Pharmaceuticals to Participate at the H.C. Wainwright Global Investment Conference

FORT WORTH, Texas, May 20, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on...

TFFP : 0.0650 (-60.05%)
TFF Pharmaceuticals, Inc. (TFFP) Q1 2022 Earnings Call Transcript

TFFP earnings call for the period ending March 31, 2022.

TFFP : 0.0650 (-60.05%)
TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

Announced Collaboration with Catalent to Further Expand Thin Film Freezing Applications with a Focus on Biologic Drug Development Announced Second CRADA...

TFFP : 0.0650 (-60.05%)
TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)

Thin Film Freezing Technology Co-Inventor Dr. Robert O. Williams III to Deliver Platform Presentation of Data on Stabilizing and Delivering Antivirals,...

TFFP : 0.0650 (-60.05%)
TFF Pharmaceuticals to Hold First Quarter 2022 Financial and Business Results Conference Call on May 11, 2022

Company conference call and webcast at 4:30 PM ET...

TFFP : 0.0650 (-60.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar